EDGE
Get a demo
Log In
All Updates

All Updates

icon
Filter
Industry news
Chinese scientists achieve first-ever diabetes cure using cell therapy
Cell & Gene Therapy
May 27, 2024
This week:
Product updates
Stability AI launches Stable Diffusion 3 Medium, a text-to-image model
Foundation Models
Yesterday
Product updates
Microsoft discontinues GPT Builder in Copilot
Generative AI Applications
Yesterday
Funding
BlinqIO raises USD 5 million in funding to expand operations
Generative AI Applications
Yesterday
Product updates
Databricks launches innovations to Mosaic AI for production-quality applications
Generative AI Infrastructure
Yesterday
M&A
Rebellions and Sapeon Korea merge to challenge global AI chip leader
Generative AI Infrastructure
Yesterday
M&A
Pluxee to acquire Cobee; expands employee benefits offering
Remote Work Infrastructure
Yesterday
Product updates
Space and Time launches 'Proof of SQL' solution on GitHub
Enterprise Blockchain Solutions
Yesterday
Partnerships
Lido partners with Mellow Finance to launch liquid restaking vaults
Decentralized Finance (DeFi)
Yesterday
Funding
Rivia raises EUR 3 million in seed funding
Clinical Trial Technology
Yesterday
Partnerships
Product updates
Databricks and Shutterstock collaborate to launch enterprise-optimized ImageAI model
Generative AI Infrastructure
Yesterday
Cell & Gene Therapy

Cell & Gene Therapy

May 27, 2024

Chinese scientists achieve first-ever diabetes cure using cell therapy

Industry news

  • A Chinese research team at the Shanghai Changzheng Hospital has successfully achieved the world's first cure for diabetes using stem-cell therapy. The treatment involved using the patient's own cells to eliminate the need for insulin and oral medication to control blood sugar levels.

  • The 59-year-old type 2 diabetes patient underwent the cell transplant in July 2021 and did not require external insulin injections in 11 weeks’ time. By the end of the first year, the patient completely discontinued using oral medication to control blood sugar levels, making this a potentially significant leap in diabetes treatment.

  • The researchers' breakthrough treatment revolves around islet transplants. They have effectively transformed the patient's peripheral blood mononuclear cells into "seed cells," which can form pancreatic islet tissue in a controlled environment.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.